32 results
8-K
EX-10.1
RKDA
Arcadia Biosciences Inc
14 Feb 24
Departure of Directors or Certain Officers
4:14pm
, business reputation or personal reputation; provided that you may respond accurately and fully to any question, inquiry or request for information
424B5
RKDA
Arcadia Biosciences Inc
16 Aug 22
Prospectus supplement for primary offering
9:44am
of management attention and resources, which could significantly harm our profitability and reputation.
Future sales of substantial amounts of our Common
8-K
EX-10.1
jgtnhajb2toblld2cm8
20 Dec 21
Arcadia Biosciences (RKDA) Appoints Kevin Comcowich to Interim CEO
5:03pm
8-K
EX-10.1
yc9vv 598o
7 Sep 21
Arcadia Biosciences Announces Leadership Transition
4:48pm
424B3
u38jmeq
12 Feb 21
Prospectus supplement
6:02am
424B5
mw4m3k5dd 389
22 Dec 20
Prospectus supplement for primary offering
12:17pm
8-K
EX-99.1
1ivxb7k7iben8f0p5
25 Mar 20
Arcadia Biosciences Announces Fourth-Quarter and Full-Year 2019 Financial Results and Business Highlights
4:10pm
424B5
1tb5kd ahmc
9 Sep 19
Prospectus supplement for primary offering
5:10pm
8-K
EX-10.1
xdus5o8
28 Aug 19
Departure of Directors or Certain Officers
4:39pm
424B5
te5g0symemdwyunsfm
14 Jun 19
Prospectus supplement for primary offering
10:16am
8-K
EX-99.1
fj78tv9y
8 May 19
Arcadia Biosciences Announces First-Quarter 2019 Financial Results and Business Highlights
4:16pm